Healthcare Access for Patients With Inflammatory Bowel Disease in the United States: A Survey by the Crohn's & Colitis Foundation

被引:1
|
作者
Jordan, Ariel A. [1 ]
Bhat, Shubha [2 ,3 ]
Ali, Tauseef [4 ]
Brunskill, Sarah R. [5 ]
Clusen, Nancy A. [5 ]
Maltz, Ross M. [6 ,7 ]
Moise, Ced [5 ]
Sun, Xiaofan [5 ]
Thomas, Harry J. [8 ]
Ray, Cassie [9 ]
Harkins-Schwarz, Mary [9 ]
Ehrlich, Orna G. [9 ]
机构
[1] Univ Michigan, Dept Internal Med, Ann Arbor, MI USA
[2] Cleveland Clin Fdn, Dept Pharm, Cleveland, OH USA
[3] Cleveland Clin Fdn, Dept Digest Dis Inst, Cleveland, OH USA
[4] SSM Hlth St Anthony Hosp Digest Care, Crohns & Colitis Ctr, Oklahoma City, OK USA
[5] Mathematica, Princeton, NJ USA
[6] Nationwide Childrens Hosp, Div Pediat Gastroenterol Hepatol & Nutr, Columbus, OH USA
[7] Ohio State Wexner Med Ctr, Dept Pediat, Columbus, OH USA
[8] Austin Gastroenterol, Austin, TX USA
[9] Crohns & Colitis Fdn, 733 Third Ave,Suite 510, New York, NY 10017 USA
关键词
inflammatory bowel disease; insurance; barriers to care; Crohn's disease; ulcerative colitis; BARRIERS;
D O I
10.1093/ibd/izae237
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background A prior survey disseminated in 2017 identified that healthcare access barriers exist and significantly affect patients with inflammatory bowel disease (IBD). We sought to identify, through an updated survey, the healthcare access barriers that patients continue to face, with a focus on socioeconomic factors and patient awareness of resources to navigate existing barriers.Methods A 52-question online survey evaluating (1) access to healthcare professionals, medications, and procedures; (2) associated financial challenges; and (3) patient awareness of education and advocacy tools to navigate IBD care barriers, was disseminated through multiple channels to IBD patients and their caregivers.Results Of the 2281 completed responses, patients on advanced specialty medications, younger than 65 years of age, or on employer insurance experienced significantly greater issues with insurance barriers to accessing medications and coverage of medically necessary tests/treatments. Patients who live in areas of concentrated poverty were more likely to experience poor health outcomes when subjected to step therapy compared to patients who did not. Additionally, patients were more likely to experience one or more financial barriers or trade-offs if the patient used an advanced specialty medicine or lived in an area with concentrated poverty.Conclusions While there have been significant and numerous advancements in IBD treatments, patients with IBD continue to experience barriers to healthcare access and treatment and financial struggles. Ongoing awareness and advocacy efforts focused on healthcare system reform and related policies to further minimize care disparities and barriers remain vital. Patients with inflammatory bowel disease in the United States experience financial struggles and barriers to healthcare access and treatment. Ongoing awareness and advocacy efforts focused on healthcare system reform and related policies to minimize care disparities and barriers remain vital. Graphical Abstract
引用
收藏
页数:14
相关论文
共 50 条
  • [21] The Prevalence of Inflammatory Bowel Disease in the United States Military Healthcare Population
    Armbruster, Steven
    Betteridge, John
    Maydonovitch, Corinne
    Veerappan, Ganesh
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S445 - S445
  • [22] THE TOTAL DIRECT COST OF HEALTHCARE. IN THE UNITED STATES IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS: AN AGE SPECIFIC ANALYSIS
    Lichtenstein, Gary R.
    Shahabi, Ahva
    Seabury, Seth A.
    Lakdawalla, Darius
    Green, Sarah G.
    Baldassano, Robert N.
    GASTROENTEROLOGY, 2017, 152 (05) : S448 - S448
  • [23] Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn's & Colitis Foundation: Charting the Future of Pediatric IBD
    Picoraro, Joseph A.
    Lee, Dale
    Heller, Caren A.
    Weaver, Alandra
    Hyams, Jeffrey S.
    Conklin, Laurie S.
    Otley, Anthony
    Ziring, David
    Kugathasan, Subra
    Rosh, Joel R.
    Mulberg, Andrew
    Denson, Lee A.
    Kappelman, Michael D.
    Grossman, Andrew B.
    Bousvaros, Athos
    Park, K. T.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (01) : 27 - 32
  • [24] Colitis and Crohn's Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
    Sood, Ajit
    Ahuja, Vineet
    Midha, Vandana
    Sinha, Saroj Kant
    Pai, C. Ganesh
    Kedia, Saurabh
    Mehta, Varun
    Bopanna, Sawan
    Abraham, Philip
    Banerjee, Rupa
    Bhatia, Shobna
    Chakravartty, Karmabir
    Dadhich, Sunil
    Desai, Devendra
    Dwivedi, Manisha
    Goswami, Bhabhadev
    Kaur, Kirandeep
    Khosla, Rajeev
    Kumar, Ajay
    Mahajan, Ramit
    Misra, S. P.
    Peddi, Kiran
    Singh, Shivaram Prasad
    Singh, Arshdeep
    INTESTINAL RESEARCH, 2020, 18 (04) : 355 - 378
  • [25] The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation (vol 26, pg 1, 2020)
    Park, K. T.
    Ehrlich, Orna G.
    Allen, John I.
    Meadows, Perry
    Szigethy, Eva M.
    Henrichsen, Kim
    Kim, Sandra C.
    Lawton, Rachel C.
    Murphy, Sean M.
    Regueiro, Miguel
    Rubin, David T.
    Engel-Nitz, Nicole M.
    Heller, Caren A.
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (07) : 1118 - 1118
  • [26] Fournier's Gangrene Complicating Inflammatory Bowel Disease: Is it Ulcerative Colitis or Crohn's Disease?
    Rustagi, Tarun
    Njei, Basile
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S431 - S431
  • [27] Effect of Obesity on Inflammatory Bowel Disease (Ulcerative Colitis vs Crohn's Disease)
    Dasu, Neethi
    Khalid, Yaser
    Blair, Brian
    Walters, Richard
    Chhoun, Christopher
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S678 - S679
  • [28] Experimental Inflammatory Bowel Disease: Lessons for the Treatment of Crohn's Disease and Ulcerative Colitis
    Ivan Fuss
    Pediatric Research, 1999, 45 : 746 - 746
  • [29] Regional survey on satisfaction with healthcare in inflammatory bowel disease patients
    Borzan, V.
    Fric, V. Orsic
    Borzan, B.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S359 - S359
  • [30] Does inflammatory bowel disease (Unclassified) evolve into Crohn's disease or ulcerative colitis?
    Paul, S. P.
    Spray, C.
    Basude, D.
    Sandmann, S.
    Ramani, R.
    Sandhu, B. K.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S407 - S407